Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair
Julien Dreyfus,Maurizio Taramasso,Karl-Patrik Kresoja,Hazem Omran,Christos Iliadis,Giulio Russo,Marcel Weber,Luis Nombela-Franco,Rodrigo Estevez Loureiro,Jörg Hausleiter,Azeem Latib,Lukas Stolz,Fabien Praz,Stephan Windecker,Jose Luis Zamorano,Ralph Stephan von Bardeleben,Gilbert H L Tang,Rebecca Hahn,Edith Lubos,John Webb,Joachim Schofer,Neil Fam,Alexander Lauten,Giovanni Pedrazzini,Josep Rodés-Cabau,Mohammed Nejjari,Luigi Badano,Hannes Alessandrini,Dominique Himbert,Horst Sievert,Kerstin Piayda,Erwan Donal,Thomas Modine,Georg Nickenig,Roman Pfister,Volker Rudolph,Jordan Bernick,George A Wells,Jeroen Bax,Philipp Lurz,Maurice Enriquez-Sarano,Francesco Maisano,David Messika-Zeitoun,TRIGISTRY Investigators,Nina Ajmone-Marsan,Philipp Bartko,Baptiste Bazire,Giovanni Benfari,Yohan Bohbot,Manuel Carnero-Alcazar,Vincent Chan,Augustin Coisne,Juan Crestanello,Michele De Bonis,Fabien Doguet,Florian Eggenspieler,Andrea Eixerés-Esteve,Damien Eyharts,Michele Flagiello,Xavier Galloo,Mara Gavazzoni,Gilbert Habib,Gregor Heitzinger,Bernard Iung,Fernando Juarez-Casso,Karl-Patrick Kresoja,Yoan Lavie-Badie,Thierry Le Tourneau,Pascal Lim,Yannick Mbaki,Hector Michelena,Denisa Muraru,Martin Nicol,Jean-François Obadia,Costin Radu,Kenza Rahmouni El Idrissi,Elisabeth Riant,Tobias Ruf,Alessandra Sala,Christine Selton-Suty,Thomas Senage,Jacques Tomasi,Yan Topilsky,Christophe Tribouilloy,Florence Viau
DOI: https://doi.org/10.1016/j.jcin.2024.04.023
2024-06-24
Abstract:Background: The safety profile of transcatheter tricuspid valve (TTV) repair techniques is well established, but residual tricuspid regurgitation (TR) remains a concern. Objectives: The authors sought to assess the impact of residual TR severity post-TTV repair on survival. Methods: We evaluated the survival rate at 2 years of 613 patients with severe isolated functional TR who underwent TTV repair in TRIGISTRY according to the severity of residual TR at discharge using a 3-grade (mild, moderate, and severe) or 4-grade scheme (mild, mild to moderate, moderate to severe, and severe). Results: Residual TR was none/mild in 33%, moderate in 52%, and severe in 15%. The 2-year adjusted survival rates significantly differed between the 3 groups (85%, 70%, and 44%, respectively; restricted mean survival time [RMST]: P = 0.0001). When the 319 patients with moderate residual TR were subdivided into mild to moderate (n = 201, 33%) and moderate to severe (n = 118, 19%), the adjusted survival rate was also significantly different between groups (85%, 80%, 55%, and 44%, respectively; RMST: P = 0.001). Survival was significantly lower in patients with moderate to severe residual TR compared to patients with mild to moderate residual TR (P = 0.006). No difference in survival rates was observed between patients with no/mild and mild to moderate residual TR (P = 0.67) or between patients with moderate to severe and severe residual TR (P = 0.96). Conclusions: The moderate residual TR group was heterogeneous and encompassed patients with markedly different clinical outcomes. Refining TR grade classification with a more granular 4-grade scheme improved outcome prediction. Our results highlight the importance of achieving a mild to moderate or lower residual TR grade during TTV repair, which could define a successful intervention.